12th week of 2012 patent applcation highlights part 48 |
Patent application number | Title | Published |
20120071515 | NITROPYRIDINYL ETHYLENEIMINE COMPOUND, THE PHARMACEUTICAL COMPOSITION CONTAINING IT, THE PREPARATION METHOD AND USE THEREOF - The present invention discloses a nitropyridinyl ethyleneimine compound as shown in the formula I and a preparation method of the same, as well as use of the compound in manufacture of a prodrug and in manufacture of a drug for treating a tumor. | 2012-03-22 |
20120071516 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM - Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity. | 2012-03-22 |
20120071517 | 2-PYRIDINYLETHYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS FUNGICIDES - The invention discloses a compound of general formula (I) | 2012-03-22 |
20120071518 | Treatment of Sepsis with 5-Ethyl-1-Phenyl-2(1H)-Pyridone - A pharmaceutical composition comprising 5-ethyl-1-phenyl-2-(1H)-pyridone (5-EPP) and its use for the treatment of sepsis are disclosed. | 2012-03-22 |
20120071519 | CRYSTALLINE FORMS OF A FACTOR Xa INHIBITOR - Provided herein are crystalline forms of a maleate salt of betrixaban, compositions and methods of preparation or use thereof. | 2012-03-22 |
20120071520 | CRYSTALLINE PHASES OF 2'--BIPHENYL-2-CARBOXYLIC ACID (2-PYRIDIN-3-YL-ETHYL)-AMIDE - The present invention relates to polymorphic forms and solvates of 2′-{[2-(4-methoxy-phenyl)-acetylamino]-methyl]}-biphenyl-2-carboxylic acid (2-pyhdin-3-yl-ethyl)-amide, processes for their preparation and their use, in particular for the preparation of medicaments. | 2012-03-22 |
20120071521 | CONCENTRATED, NON-FOAMING SOLUTION OF QUATERNARY AMMONIUM COMPOUNDS AND METHODS OF USE - A concentrated quaternary ammonium compound (QAC) solution comprising a QAC with a concentration greater than about 10% by weight and at least one solubility enhancing agent, such as an alcohol, is disclosed. A diluted QAC solution is useful on food products to prevent microbial growth on the food from a broad spectrum of foodborne microbial contamination. Also disclosed is a method of contacting food products with the dilute QAC for an application time of at least 0.1 second. Foods that can be treated by this method are meat and meat products, seafood, vegetables, fruit, dairy products, pet foods and snacks, and any other food that can be 10 treated and still retain its appearance and texture. One of the treatment methods is spraying and misting the QAC solutions on the food products for an application time of at least 0.1 second to prevent broad spectrum foodborne microbial contamination. | 2012-03-22 |
20120071522 | THERMAL STABILIZATION OF BIOCIDES IN MATRIX COMPOSITIONS PROCESSED AT ELEVATED TEMPERATURES - A composition includes (a) a matrix, (b) a biocide, and (c) an antioxidant, in which said biocide exhibits thermal stability at matrix processing temperatures up to 250° C. | 2012-03-22 |
20120071523 | BENZOFURAN-4,5-DIONES AS SELECTIVE PEPTIDE DEFORMYLASE INHIBITORS - The instant invention provides novel benzofuran-4,5-diones and pharmaceutical compositions thereof useful for inhibiting PDF and for treating proliferative and infectious diseases. Compounds may be selective for eukaryotic (e.g., human) PDF or prokaryotic PDF. | 2012-03-22 |
20120071524 | COMPOUNDS FOR TREATMENT OF CANCER - The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating cancer and drug-resistant tumors, e.g. melanoma, metastatic melanoma, drug resistant melanoma, prostate cancer and drug resistant prostate cancer. | 2012-03-22 |
20120071525 | ANTI-MICROBIAL COMPOSITION - The present invention provides an anti-microbial composition comprising (i) an antimicrobial agent with surfactant properties, (ii) a siloxane selected from those having the formulae V:(H | 2012-03-22 |
20120071526 | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS - Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, polycystic ovary syndrome, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are disclosed. | 2012-03-22 |
20120071527 | THERAPEUTIC COMPOUNDS - The invention provides compounds of formula I: | 2012-03-22 |
20120071528 | METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA - The invention is directed to novel compounds of Formula I: | 2012-03-22 |
20120071529 | Tetrazole Compounds Which Selectively Modulate The CB2 Receptor - Compounds of formula (I) | 2012-03-22 |
20120071530 | AGROCHEMICAL COMPOSITION AND METHOD FOR PREPARING AND USING THE SAME - An agrochemical composition comprises an azole active ingredient and an N,N-dialkyl long chain alkylamide. The N,N-dialkyl long chain alkylamide is present in sufficient amount to prevent or inhibit the crystallization of the azole derivative during the application of the composition to a locus. Preferred N,N-Dialkyl long chain alkylamide(s) comprised in the composition is/are selected from the group consisting of compounds of the formula (I): in which (a) R | 2012-03-22 |
20120071531 | Use of Fungicides for the Treatment of Fish Mycoses - Process for the protection of fish and invertebrates and all their stages of development against or for the treatment of mycoses caused by fungi of the genera | 2012-03-22 |
20120071532 | NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDE - Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use. | 2012-03-22 |
20120071533 | ANTI-FUNGAL FORMULATION - Provided herein are compositions and formulations comprising an antifungal agent. Pharmaceutical compositions comprising luliconazole in an amount effective for the treatment of onychomycosis are provided. Also provided are methods for treating dermatomycoses and onychomycosis using the compositions and formulations. | 2012-03-22 |
20120071534 | LXR MODULATORS - Compounds, pharmaceutically acceptable salts, isomers, or prodrugs thereof, of the invention are disclosed, which are useful as modulators of the activity of liver X receptors (LXR). Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed. | 2012-03-22 |
20120071535 | ESTROGEN RECEPTOR MODULATORS AND USES THEREOF - Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors. | 2012-03-22 |
20120071536 | N-[(2-AZABICYCLO[2.1.1]HEX-1-YL)-ARYL-METHYL]-BENZAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF - The invention relates to N-[(2-aza-bicyclo[2.2.1]hex-1-yl)-aryl-methyl]-benzamide derivatives of the general formula (I) where: R is a hydrogen atom or a (C | 2012-03-22 |
20120071537 | New Oral Formulation - The present invention relates to a pharmaceutical composition, in particular to a composition for administering active agents which are poorly soluble in aqueous media, and/or which are acid sensitive. | 2012-03-22 |
20120071538 | PHARMACEUTICAL FORMULATONS - Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and an open matrix network which is an inert water-soluble or water-dispersible carrier material. Desmopressin formulated in this way is useful for voiding postponement, or the treatment or prevention of incontinence, primary noctural enuresis (PNE), nocturia or central diabetes insipidus. Peptides other than desmopressin can also be formulated in this way. | 2012-03-22 |
20120071539 | COMPOUNDS AND METHODS FOR MODULATING THE SILENCING OF A POLYNUCLEOTIDE OF INTEREST - Methods and compositions comprising chemical compounds that modulate the silencing of a polynucleotide of interest in a cell are provided. Such chemical compounds when used in combination with an appropriate silencing element can be used to modulate (increase or decrease) the level of the polynucleotide targeted by the silencing element. Methods of using such compositions both in therapies involving RNAi-mediated suppression of gene expression, as well as, in vitro methods that allow for the targeted modulation of expression of a polynucleotide of interest are provided. Pharmaceutical or cosmetic compositions comprising such compounds and silencing elements also are disclosed. Methods for screening a compound of interest for the ability to modulate the activity of a heterologous silencing element also are provided. | 2012-03-22 |
20120071540 | Compositions and Methods Using siRNA Molecules and siRNA Cocktails for the Treatment of Breast Cancer - The present invention provides small interfering RNA (siRNA) molecules, compositions containing the molecules, and methods of using the molecules and compositions to treat breast cancer. In one aspect, a multi-targeted siRNAi cocktail is disclosed. The siRNA molecules may be encapsulated in nanoparticles to further enhance their anti-cancer activity. The compositions may also be used in combination with other anti-cancer agents, such as bevacizumab. | 2012-03-22 |
20120071541 | Micro-RNA Associated With Rheumatoid Arthritis - An object of the present invention is to provide a novel marker for rheumatoid arthritis (RA), and more specifically, to provide a marker whose expression may be specifically increased or decreased in RA. Another object of the present invention is to confirm whether or not miRNA serving as the marker is involved as the etiology of RA, and to provide an inspection method for RA and a therapeutic agent for RA each using the miRNA involved. The marker includes miRNA (for example, miR124 | 2012-03-22 |
20120071542 | Application of Highly Conserved Domain Sequences From Viral Genome As Template To Design Therapeutic Slirnas - This invention relates to the application of the highly conserved sequences of viral genome, especially from a highly conserved domain of enteroviral genome as templates to design target small ligand RNAs (sliRNAs). The resulting sliRNAs are therapeutically active ingredients in the treatment of the related diseases caused by pathological angiogenesis. | 2012-03-22 |
20120071543 | FORMULATIONS OF DILUTED GENETIC MATERIAL AND METHODS FOR MAKING SAME - Formulations of highly diluted genetic material are disclosed. The genetic material may be human genetic material that is associated with a health effect in humans. For example, the genetic material may cause, ameliorate, reduce, or otherwise affect any form of illness, disease, and/or overall wellness in humans. The formulations are made by serially diluting an initial mixture that includes the genetic material. In one embodiment, a patient's genetic material is tested and the results are used to prepare a formulation specifically for the genetic predispositions and/or indicators exhibited by the patient. The formulations include homeopathic remedies. | 2012-03-22 |
20120071544 | Methods For Identifying Compounds Effective To Increase The Expression Or Activity Of Aspartyl Aminopeptidase In Mammalian Pancreatic Islet Cells, And Methods For Decreasing Angiotensin II Levels In Mammalian Pancreatic Islet Cells - The methods provided herein are based on the discovery, as described in more detail herein, that aspartyl aminopeptidase (DAP) is expressed in mammalian pancreatic islet cells and that increased DAP expression results in decreased angiotensin II (Ang II) levels in the islet cells. Methods are provided for identifying compounds effective to increase the expression and/or activity of DAP in mammalian pancreatic islet cells and thereby are effective to decrease Ang II levels in the islet cells. Methods are also provided for decreasing Ang II levels in a subject having Ang II induced pancreas islet cell dysfunction and/or suffering or susceptible to type 1 diabetes, as well as for the treatment or prevention of type 1 diabetes comprising administering to the subject a therapeutically effective amount of the compound identified according to the methods herein. | 2012-03-22 |
20120071545 | COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL AND MYCOBACTERIAL INFECTIONS - A novel method of treating and preventing bacterial diseases is provided. In particular, the present invention relates to compositions and methods for inhibition of Gram negative, Gram positive and acid fast bacilli in general and tuberculosis (TB), | 2012-03-22 |
20120071546 | Novel Glutamic Acid Decarboxylase (GAD) Chimera And Methods Of Use - The invention relates to a novel Glutamic Acid Decarboxylase (GAD). More specifically, novel DNA and protein sequences relating to GAD. Additionally, the invention discloses a novel composition and related methods for treating neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, epilepsy, and the like, using viral and non-viral delivery systems that deliver therapeutic agents to specific regions of the brain. More specifically, using an adeno-associated viral vector to deliver a nucleotide sequence encoding a novel glutamic acid decarboxylase (GAD) to specific regions of the brain that are over stimulated or disinhibited in various diseases, including neurodegenerative diseases | 2012-03-22 |
20120071547 | COMPOUNDS FROM SOFT CORAL, METHOD OF PREPARATION AND PHARMACEUTICAL USES THEREOF - The invention relates to compounds from the soft coral and the generation thereof. The invention also relates to the uses of the compounds from the soft coral in inhibiting inducible nitric oxide synthase and/or cyclooxygenase-2 and in treating the diseases associated with inducible nitric oxide synthase and/or cyclooxygenase-2. | 2012-03-22 |
20120071548 | Therapeutic compositions - Compositions comprising ketone bodies and/or their metabolic precursors are provided that are suitable for administration to humans and animals and which have the properties of, inter alia, (i) increasing cardiac efficiency, particularly efficiency in use of glucose, (ii) for providing energy source, particularly in diabetes and insulin resistant states and (iii) treating disorders caused by damage to brain cells, particularly by retarding or preventing brain damage in memory associated brain areas such as found in Alzheimer's and similar conditions. | 2012-03-22 |
20120071549 | ANTI-INFLAMMATORY COMPOSITION CONTAINING MACROLACTIN A AND A DERIVATIVE THEREOF AS ACTIVE INGREDIENTS - The present invention relates to an anti-inflammatory use of macrolactin compounds such as macrolactin A, 7-O-malonyl macrolactin A and 7-O-succinyl macrolactin A, which are produced from a novel | 2012-03-22 |
20120071550 | Synergistic combinations of cartonoids and polyphenols - The present invention provides a therapeutic composition comprising one or more polyphenols and one or more carotenoids selected from the group consisting of lutein, lycopene and beta-carotene. The invention also provides methods for inhibiting or reducing the production of superoxide ions, NO, TNF-alpha and/or PGE | 2012-03-22 |
20120071551 | ETHANOLIC EXTRACTS OF HASS AVOCADO SEEDS, Persea americana Mill., AND ITS USE AS MITICIDE FOR Panonychus citri, Oligonychus yothersi, AND Tetranychus cinnabarinus, AND AS AN INSECTICIDE FOR Trialeurodes vaporariorum - An ethanolic extract of avocado seeds with a composition of 2-Furfuraldehyde (1,00%), 5-Methylundecane (1,05%), (11Z)-Pentadecenal (0,98%), (11Z)-Hexadecenal (2,35%), (3E)-Nonadecene (1,07%), 2-Tetradecylfuran (5,58%), 2-Pentadecylfuran (7,10%), 2-Hexadecylfuran (6,52%), 2-(1Z-Heptadecenyl) furan (2,85%), 2-(1E-Pentadecenyl) furan (2,15%), 2-(1E-Heptadecenyl) furan (5,60%), 2-(8Z, 11Z-Heptadecadienyl) furan (5,49%), 2-(8Z, 11 E-Heptadecadienyl) furan (33,53%), 2-(1 E, 8Z, 11Z-Heptadecatrienyl) furan (15,56%), and other unidentified compounds (9,17%), useful as miticide and insecticide is described. | 2012-03-22 |
20120071552 | Zinc-Monocysteine Complex and Method Of Using Zinc-Cysteine Complexes - A method of providing zinc to a subject in need of treatment includes administering to the subject an effective amount of a zinc-cysteine complex. The zinc-cysteine complex is preferably a zinc-monocysteine complex. The complexes of zinc-cysteine of the present invention increase the activity of antioxidant enzymes catalase and glutathione peroxidase, and the antioxidant protein metallothionein. The complexes of zinc-cysteine of the present invention protect retinal pigment epithelial cells from increasing hydrogen peroxide concentrations. | 2012-03-22 |
20120071553 | CHLORINE-FREE WATER TREATMENT - A combination of the surfactant SDS with levulinic acid produces a synergistic effect in relation to the antimicrobial effectiveness of the individual compounds, allowing the formulation of compositions wherein the active agents are present at concentrations effective to reduce bacterial and fungal counts in liquids, including, but not limited to, water and other beverages, without altering the organoleptic properties of the treated food substance. The active agents are FDA-approved as food additives, and the treated beverages can be any aqueous-based beverage consumable by humans or animals. The levulinic acid-SDS combination is also suitable for reducing or eliminating the microbial population on the surfaces of water and beverage containers, and the machinery and facilities for the bottling of liquids. | 2012-03-22 |
20120071554 | DEUTERATED 2-PROPYLPENTANOIC ACID COMPOUNDS - Described herein are novel analogs of 2-propylpentanoic acid, pharmaceutical compositions comprising the same, and methods of using the same for the treatment of diseases or conditions that are beneficially treated by administering a GABAAergic transmission enhancer and/or a histone deacetylase (HDAC) inhibitor. | 2012-03-22 |
20120071555 | COMPOSITIONS OF ABSCISIC ACID FOR ANIMAL HEALTH - The invention relates to compositions comprising abscisic acid, and/or salts, derivatives and analogs thereof, and methods of using the same for improving the health and offspring mortality of animals. | 2012-03-22 |
20120071556 | PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS OF ABSCISIC ACID - The invention relates to compositions comprising abscisic acid, and/or salts, derivatives and analogs thereof, and methods of pharmaceutical and/or nutraceutical use. | 2012-03-22 |
20120071557 | ANIMAL FEED COMPOSITIONS OF ABSCISIC ACID - The invention relates to compositions comprising abscisic acid, and/or salts, and derivatives thereof, and methods of using the same for improving the health, growth, and feed efficiency of livestock and fish as well as the quantity of meat produced in livestock in particular. | 2012-03-22 |
20120071558 | COMPOSITIONS OF VERY LONG CHAIN POLYUNSATURATED FATTY ACIDS AND METHODS OF USE - The present invention relates to processes for production of Very Long Chain Polyunsaturated Fatty Acids (VLC-PUFAs). The present invention also relates to compositions (e.g., nutritional supplements, food products, and pharmaceutic compositions) containing such VLC-PUFAs. In one embodiment, the present invention is directed to methods for biosynthesis and production of the VLC-PUFAs described herein (particularly C28-C40 PUFAs, also referred to herein as supraenes or supraenoics) by the expression, in a production host cell, of the full or partial sequence(s) of Elovl4 DNA/mRNA nucleic acids or ELOVL4 protein sequences encoded thereby, from any species (prokaryotic or eukaryotic) for use in the biosynthesis, production, purification and utilization of VLC-PUFAs in particular by the elongation of C18-C26 saturated fatty acids and PUFAs. The composition of the invention comprises, in various embodiments, a dietary supplement, a food product, a nutritional formulation, a pharmaceutical formulation, a humanized animal milk, an infant formula, and a cosmetic item and for example. A pharmaceutical formulation can include, but is not limited to: a composition for enhancing neural development and function, a drug for treatment of neurodegenerative disease, an ocular disorder, a retinal disorder, age related maculopathy, a fertility disorder, particularly regarding sperm or testes, or a skin disorder. | 2012-03-22 |
20120071559 | METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdG - Methods of quantifying a N | 2012-03-22 |
20120071560 | MONOAMINE REUPTAKE INHIBITORS - The invention provides bupropion analogue compounds capable of inhibiting the reuptake of one or more monoamines. The compounds may selectively bind to one or more monoamine transporters, including those for dopamine, norepinephrine, and serotonin. Such compounds may be used to treat conditions that are responsive to inhibition of the reuptake of monoamines, including addiction, depression, and obesity. | 2012-03-22 |
20120071561 | Methods And Compositions For Prevention And Treatment Of Inflammatory Disease, Autoimmune Disease And Transplant Rejection - The invention provides compositions and methods for reducing one or more symptoms of an autoimmune disease, inflammatory disease, and/or transplant rejection, by the administration to a subject in need thereof a pharmaceutically effective amount of a purified compound of any one of Formulae A-E. The invention's methods are useful for the prevention, amelioration, and treatment of autoimmune disease, inflammatory disease, and/or transplant rejection. | 2012-03-22 |
20120071562 | 2alpha-Methyl-19-Nor-(20S)-1alpha-Hydroxy-Bishomopregnacalciferol and Its Uses - This invention discloses 2α-methyl-19-nor-(20S)-vitamin D analogs, and specifically 2α-methyl-19-nor-(20S)-1α-hydroxy-bishomopregnacalciferol and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differentiation to the monocyte thus evidencing use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. This compound also has little, if any, calcemic activity and therefore may be used to treat autoimmune disorders or inflammatory diseases in humans as well as renal osteodystrophy. This compound may also be used for the treatment or prevention of obesity. | 2012-03-22 |
20120071563 | STABILIZER - The present invention relates to a stabilizer comprising starch that comprises at least one ester group corresponding to the formula (I) | 2012-03-22 |
20120071564 | Emulsions Based On Hydroxyl Compounds Bearing Silyl Groups - The invention relates to emulsions containing hydroxyl compound bearing silyl groups, to the production and to the use thereof | 2012-03-22 |
20120071565 | POWDERY OR GRANULATED COMPOSITION COMPRISING A COPOLYMER, A DICARBOXYLIC ACID AND A FATTY MONOCARBOXYLIC ACID - A powdery or granulated composition, containing: (a) a copolymer containing, in polymerized form, a C | 2012-03-22 |
20120071566 | Bioabsorbable Polymeric Compositions, Processing Methods, and Medical Devices Therefrom - Novel bioabsorbable polymeric blends are disclosed. The blends have a first component that is a polylactide polymers or a copolymer of lactide and glycolide and a second component that is poly(p-dioxanone) polymer. The novel polymeric blends provide medical devices having dimensional stability. Also disclosed are novel bioabsorbable medical devices made from these novel polymer blends, as well as novel methods of manufacture. | 2012-03-22 |
20120071567 | FRUIT FLAVORED COCOA BUTTER BASED CONFECTION - A fruit flavored confection made of a fruit based anhydrous component, along with sweeteners dairy and suitable confectionary fat wherein the intimate incorporation of the fruit based component and the acidic pH of the confection results in a vibrant fruit flavor profile. | 2012-03-22 |
20120071568 | Cosmetic Composition - An object of the invention is to provide a cosmetic composition that is not drippy during makeup removal, has good skin spreadability during use, has a refreshing feeling in use, and provides a high cleansing effect, and in particular, to provide a cleansing composition. The cosmetic composition according to the invention is characterized by comprising (A) an alkyl ethylene oxide surfactant having an HLB of 8 to 13, (B) 10 to 40 mass % of an oil component, and (C) water, wherein the composition is a discontinuous-micellar cubic liquid-crystal phase. Also the cosmetic composition is characterized by comprising the above composition as the outer phase and (B | 2012-03-22 |
20120071569 | PROCESS FOR PRODUCING GEL OF CARBOXYMETHYL CELLULOSE ALKALI METAL SALT - To provide a method for producing a gel of a carboxymethyl cellulose alkali metal salt, in which a gel having high elasticity and strength and also having excellent water retention and durability can be obtained inexpensively and simply. | 2012-03-22 |
20120071570 | NOVEL ACYL ACIDIC AMINO ACID ESTER - Provided is a novel oily material that spreads smoothly upon application and is free from stickiness, and also gives ungreasy and moisturized feeling after application, but does not give friction feeling peculiar to silicone. The invention was completed upon finding that a specific acyl acidic amino acid monosilicone monosterol ester can solve the foregoing problems. | 2012-03-22 |
20120071571 | COBALT CATALYSTS - A catalyst suitable for the Fischer-Tropsch synthesis of hydrocarbons is described comprising cobalt nanocrystallites containing a precious metal promoter, dispersed over the surface of a porous transition alumina powder wherein the cobalt content of the catalyst is ≧25% by weight, the precious metal promoter metal promoter content of the catalyst is in the range 0.05 to 0.25% by weight, and the cobalt crystallites have a average size, as determined by hydrogen chemisorption, of ≧15 nm. A method for making the catalyst is also described. | 2012-03-22 |
20120071572 | COUNTER-CURRENT MULTISTAGE FISCHER TROPSCH REACTOR SYSTEMS - The invention discloses an improved multistage fischer tropsch process scheme for the production of hydrocarbon fuels comprising feeding gaseous phase syngas and liquid stream hydrocarbons in a counter current manner such as herein described into the reaction vessel at a number of stages containing reaction catalysts; wherein fresh syngas enters into the stage where the product liquid stream leaves and the fresh liquid stream enters into the stage where the unreacted syngas leaves; wherein further the temperature of each stage can be controlled independently. More particularly the invention relates to improving the heat release in different reactors, product selectivity and reactor productivity of FT reactors. | 2012-03-22 |
20120071573 | Neutralization by Filler - The invention relates to a method for adjusting the pH value and/or for neutralizing acid and/or basic compounds, in particular degradation or decomposition products, as part of the reprocessing and recycling of in particular thermoplastic materials, in the course of which the polymer particles are permanently moved and heated in a reactor, wherein at least one filler is added for neutralization purposes, specifically in a quantity which corresponds at least to the anticipated acid or alkali load. | 2012-03-22 |
20120071574 | STONE BASED COPOLYMER SUBSTRATE - A stone based copolymer substrate includes calcium carbonate (CaCO3) from approximately fifty to eighty-five percent (50-85%) by weight and varying in size generally from 1.0 to 3.0 microns, high-density polyethylene (HDPE) from approximately two to twenty-five percent (2-25%) by weight and a biopolymer from approximately two to twenty-five percent (2-25%) by weight. The substrate may include a biodegradation additive from approximately three fourths of a percent to two percent (0.75-2%) by weight. By selectively adjusting the ranges of the substrate's components, various products can be made to replace current tree-based and plastic-based products. The substrate can be configured to be tear proof, water proof, fade resistant and fire retardant while utilizing less energy and producing less waste during its manufacture. In an exemplary embodiment of the invention, the stone used in the substrate includes limestone. | 2012-03-22 |
20120071575 | Microporous Thermoplastic Article - Surfaces of thermoplastic articles are rendered microporous by contacting the surface with a composition that includes a solvent. The article has a birefringence of 0.0001 or greater and the composition has a solvent strength configured to swell but not dissolve the polymer. | 2012-03-22 |
20120071576 | Additives for Improving Polyurethane Foam Performance - Polyurethane foam compositions and processes to make flexible polyurethane foams are disclosed. Polyurethane foam is produced in the presence of additives comprising guanidine derivatives. Improvements in physical properties such as air flow, dimensional stability, tensile, tear, elongation and foam hardness is observed when these additives are present in polyurethane formulations. In addition, these additives can minimize polymer degradation under humid ageing conditions resulting in foam products with better mechanical properties. | 2012-03-22 |
20120071577 | USE OF ISOCYANATES BASED ON RENEWABLE RAW MATERIALS - The invention relates to the use of 2,5-diisocyanato-1,4:3,6-dianhydro-2,5-dideoxy-D-manitol (I), 2,5-diisocyanato-1,4:3,6-dianhydro-2,5-dideoxy-D-glucitol (II), and/or 2,5-diisocyanato-1,4:3,6-dianhydro-2,5-dideoxy-L-iditol (III). | 2012-03-22 |
20120071578 | PRODUCING MELAMINE-FORMALDEHYDE FOAMS - The invention relates to processes for producing a melamine-formaldehyde foam comprising the consecutive steps a) and b): | 2012-03-22 |
20120071579 | THIOL GROUP- CONTAINING ADHESIVE RESIN COMPOSITION - The invention provides a light-curable adhesive resin composition, which exhibits good adhesion to adherends, including not only thermoplastic resins such as PET or polyimide, but also metal oxides such as IZO and metals such as gold. As means for solving the problems, the inventive thiol group-containing adhesive resin composition contains (A) a urethane (meta-) acrylate oligomer having a weight average molecular weight (Mw) of 5,000-40,000, (B) a (meta-) acryloyl morpholine monomer, (C) a polythiol, and (D) a photopolymerization initiator, wherein the polythiol (C) has thiol groups in an amount of 0.4 equivalents or more per 1 equivalent of the total (meta-) acrylate groups contained in the thiol group-containing adhesive resin composition. | 2012-03-22 |
20120071580 | Suturable Hybrid Superporous Hydrogel Keratoprosthesis for Cornea - The present invention features a hybrid superporous hydrogel scaffold for cornea regeneration and a method for producing the same. The hybrid hydrogel is composed of a superporous poly(2-hydroxyethyl methacrylate) (PHEMA) and poly(methyl methacrylate) (PMMA) copolymer mixed with collagen. The hybrid scaffold can be used as a suturable hybrid corneal implant or keratoprosthesis. | 2012-03-22 |
20120071581 | Bag-on-valve aerosol dispensing arrangement and chemical formulations - Additive combinations for various products to allow the product to be dispenses from a BOV aerosol dispensing arrangement. | 2012-03-22 |
20120071582 | DIRECT-TO-METAL AND EXTERIOR DURABLE NON-SKID COATING - A non-skid coating described herein attempts to overcome the deficiencies of the conventional coatings with improved external durability and color retention, a reduced level of VOCs, and direct-to-metal (DTM) adhesion using organo-siloxane chemistry. The non-skid coating has a first component having an amino-functional siloxane resin; a second component having a non-aromatic epoxy resin; a spherical filler for lowering viscosity; a pigment; a coarse aggregate; and a thixotropic agent. The amino-functional siloxane resin can be an amino-functional methyl phenyl polysiloxane, diphenyl polysiloxane or silsesquioxane-based resin. The non-aromatic epoxy resin can be cycloaliphatic or aliphatic. The first component is about 5% to 20% weight of the coating, and the second component is about 80% to 95% weight of the coating. | 2012-03-22 |
20120071583 | POLYMER COMPOSITIONS WITH IMPROVED COLD FLOW - A method for preparing a polymeric composition, the method comprising providing a polymer cement including a polymer and a solvent; introducing a cold-flow inhibitor with the polymer cement, where the cold-flow inhibitor is selected from the group consisting of vicinal diamides, vicinal diureas and vicinal amide-ureas; and isolating at least a portion of the polymer and the cold-flow inhibitor from the solvent to provide a polymeric composition including the polymer and the cold-flow inhibitor. | 2012-03-22 |
20120071584 | STRUCTURAL EPOXY RESINS CONTAINING CORE-SHELL RUBBERS - Core-shell rubbers are incorporated into epoxy adhesives. The adhesives are structural type adhesives that contain an epoxy resin and a toughener, and may contain a liquid rubber in addition to the core-shell rubber. The adhesives have good modulus and tensile strength, which are obtained without loss of elongation and adhesive properties. | 2012-03-22 |
20120071585 | EPOXY RESIN COMPOSITION, PREPREG AND FIBER-REINFORCED COMPOSITE MATERIAL - Provided is an epoxy resin composition having superior flame resistance without containing a halogen-based flame retardant, red phosphorous or phosphate ester, and a prepreg and a fiber-reinforced composite material that use the epoxy resin composition. The epoxy resin composition has as essential components thereof (A) a phosphorous-containing epoxy resin composed of a compound (a) represented by the following formula (a), (C) a novolak-type epoxy resin, and (D) an epoxy resin curing agent. A prepreg containing the epoxy resin composition and a fiber-reinforced composite material obtained by curing the prepreg are also provided. | 2012-03-22 |
20120071586 | NANOPARTICLE PULTRUSION PROCESSING AIDE - The use of nanoparticles, including surface-modified silica and calcite nanoparticles, as processing aides for pultrusion is described. The methods include combining a resin system containing a resin and the nanoparticles with continuous fibers, pultruding this combination, and at least partially curing the resin. The methods are suitable for use with a wide variety of resins and fibers, and may be used to reduce the pull-force at a fixed fiber volume loading, increase the fiber volume loading, or both. Pultruded parts made by these methods and pultruded parts with high volume loadings of fibers are also described. | 2012-03-22 |
20120071587 | USE OF CURABLE RESINS CONTAINING A PREPOLYMER BASED ON GLYCIDYL (METH)ACRYLATE FOR MAKING MATERIALS FOR USE IN SPACE - It relates to the use of curable resins containing a prepolymer based on glycidyl (meth)acrylate for making composite materials for use in space and, more particularly to composite materials entering the composition of structures intended to be deployed in space and to be stiffened after deployment. | 2012-03-22 |
20120071588 | Fiber-Containing Pasty Construction Materials - The invention relates to fiber-containing pasty construction materials, containing a) one or more fillers, b) optionally additives, characterized in that they contain c) fibers, d) one or more polymers based on one or more ethylenically unsaturated monomers, having a glass transition temperature Tg of ≧−15° C., e) ≦5% by weight hydraulically setting binders and f) water, wherein the information in % by weight relates to the dry weight of the fiber-containing pasty construction materials. | 2012-03-22 |
20120071589 | Polymer Fiber, Its Use And Process For Its Manufacture - The present invention relates to a novel polymer fiber obtainable by melt-spinning of a polymer, the use of the fiber and a process for the manufacture of the fiber. | 2012-03-22 |
20120071590 | Novel composite materials comprising a thermoplastic matrix polymer and wood particles - The present invention concerns a novel low-temperature thermoplastic wood-biopolymer composite comprised of small wood particles and a polycaprolactone (PCL) homopolymer for use in medical procedures including orthopedic casting or splinting. The material is made from a thermoplastic composite that softens when heated to approximately 60° C., after which it can be formed directly on the patient. The composite then retains its shape as it cools down. The material is composed of epsilon caprolactone homopolymer reinforced with discontinuous short length wood particles. | 2012-03-22 |
20120071591 | LIGNIN BASED MATERIALS AND METHODS OF MAKING THOSE - The present invention relates to plastic materials comprising lignin and poly (butylene succinate) (PBS) to methods of manufacturing those plastic materials and to articles obtained by molding the plastic materials of the invention. Since PBS can be obtained from renewable sources, the present invention also provides for bioplastic materials comprising lignin and PBS. The present invention also provides for plastic materials comprising lignin and PBS and at least one fiber and to articles obtained from those plastic materials that are degradable, compostable and recyclable. | 2012-03-22 |
20120071592 | COMBINATION OF SUBSTITUTED CYCLODEXTRIN COMPOUND AND ACTIVATED CARBON - The invention is a composition that can prevent formation in, or scavenge undesirable organic materials from, a polymer matrix. The composition contains cyclodextrin and particles of activated carbon. The composition can scavenge thermal decomposition products that can be produced during melt processing of a polymer, contaminants inherent in a polymer, or other types of impurities from a polymer matrix that otherwise may elute into the air, a water supply, or an ingestible material such as a food, a drug, or a beverage. Other aspects of the invention are blends of the composition with polymeric materials, methods of making blends, articles containing the composition, and methods of making articles containing the composition. | 2012-03-22 |
20120071593 | POLYMERIC DISPERSANTS AND NON-AQUEOUS DISPERSIONS - A non-aqueous pigment dispersion includes a pigment, a non-aqueous dispersion medium, and a polymeric dispersant including at least one oxalylamide structural unit according to Formula (I): | 2012-03-22 |
20120071594 | POLYTRIAZINYL COMPOUNDS AS FLAME RETARDANTS AND LIGHT STABILIZERS - Compounds consisting of an oligomer or a polymer of a 1,3,5-triazine derivative, having the general formula I: | 2012-03-22 |
20120071595 | Novel aqueous resorcinol-formaldehyde-latex dispersions, adhesion-improved fibres, processes for production thereof and use thereof - The present invention relates to novel aqueous resorcinol-formaldehyde-latex dispersion, to adhesion-improved fibres, to processes for production thereof, and to use thereof for improving adhesion in tyres. | 2012-03-22 |
20120071596 | STABILIZED POLYOLEFIN COMPOSITIONS - Disclosed are compositions comprising antioxidants and stabilizers, such as, acid scavengers or organic phosphorus stabilizers, and optionally further comprising co-stabilizers. The disclosed compositions are useful as stabilizers for polyolefins and other polymeric materials. The disclosed compositions and methods generally provide longer shelf lifes and better oxidative resistance to materials than currently available antioxidants. | 2012-03-22 |
20120071597 | Membrane based on a binder compound with tall-oil pitch - Membrane based on a binder compound with tall-oil pitch Membrane produced on the basis of a binder compound comprising a crude tall-oil pitch in a quantity of 1-65 w. %, more specifically a quantity of 20-55 w. %, even more specifically a quantity of 36-55 w. %, and a polymer in a quantity of 7-40 w. %, more specifically in a quantity of 8-20 w. %, even more specifically in a quantity of 9-17 w. %, and a filler. | 2012-03-22 |
20120071598 | Plasticised Polyvinyl Chloride - Esters of cyclohexane polycarboxylic acids are used as plasticisers for polyvinyl chloride to enable products with comparable mechanical properties to be obtained using less polyvinyl chloride. Use of these esters also produces formulations with increased stability to ultra-violet light, improved low temperature properties, lower viscosity and improved processability as well as reduced smoke on burning. The esters of cyclohexane polycarboxylic acids may be used alone or in admixture with other plasticisers when the esters of cyclohexane polycarboxylic acids may act as viscosity depressants. Fast fusing plasticisers may also be included. The formulations are particularly useful in the production of a range of goods from semi-rigid to highly flexible materials and are particularly useful in the production of medical materials such as blood bags and tubing. | 2012-03-22 |
20120071599 | AUTOMOTIVE LAMP PERIPHERAL PARTS - [Problem to be Solved] | 2012-03-22 |
20120071600 | DELAMINATION-RESISTANT MULTILAYER CONTAINER PREFORM, ARTICLE AND METHOD WITH OXYGEN BARRIER FORMULATIONS - A plastic preform, container or article includes a multilayer wall having at least one layer of a matrix resin, at least one layer of a barrier resin, an adhesion-promoting material blended with the barrier resin and/or matrix resin, and an active oxygen barrier composition blended with the barrier resin and/or matrix resin. The adhesion-promoting material promotes bonding between the barrier and matrix resin layers and includes an amine polymer, preferably an imine polymer having a number of available primary, secondary or tertiary amine groups. The matrix resin preferably is an ester-containing resin, such as PET. The barrier resin preferably is EVOH. The active oxygen barrier composition includes a metal with an additive compound, and may also include a host polymer. | 2012-03-22 |
20120071601 | RESIN COMPOSITION FOR USE IN COATED MOLDED ARTICLE - The present invention is a resin composition for use in a coated molded article including: 35 to 90 mass % of (A) a polyamide resin; 9 to 50 mass % of (B) an ABS resin; 1 to 25 mass % in total of (C) two or more kinds selected from a carboxylic acid-modified AS resin, a carboxylic acid-modified acrylic resin, a carboxylic acid-modified maleimide resin, a carboxylic acid-modified ABS resin, and a carboxylic acid-modified SEBS resin; and 2 to 80 parts by mass of (D) glass fiber and/or carbon fiber with respect to 100 parts by mass of the total of components (A), (B), and (C). | 2012-03-22 |
20120071602 | IR-REFLECTING COMPOSITIONS - A composition comprising multistage polymeric particles having an average particle diameter from 0.5 to 15 μm and a Vicker's scale hardness from 100 to 700 Kgf/mm | 2012-03-22 |
20120071603 | METHOD OF PRODUCTION OF RADIAL CONJUGATED DIENE POLYMER - An alkali metal-reacted aromatic compound which has three or more carbon atoms which are directly bonded to alkali metal atoms and aromatic rings in one molecule is used as a polymerization initiator to polymerize a monomer mixture which is contains at least one conjugated diene compound to thereby produce a radial conjugated diene polymer. Further, active ends of the polymer having active ends which is obtained by this method is made to react with a modifier which can react with the active ends to thereby produce an end-modified radial conjugated diene polymer. According to the present invention, it is possible to provide a method of production of the radial conjugated diene polymer which gives a high degree of freedom of polymer design and easy control of the polymer structure. | 2012-03-22 |
20120071604 | CURABLE SILICONE RESIN COMPOSITION - A curable silicone resin composition has excellent closed-system curability, adhesiveness, heat-resistant coloration stability, and balance between transparency and adhesive strength. The curable silicone resin composition is a curable silicone resin composition comprising 100 parts by mass of a silicone A, the weight-average molecular weight of which is 20,000 to 200,000, and which has 2 or more (meth)acryloyl groups per molecule; 10 parts by mass or more of a silicone B, the weight-average molecular weight of which is 1,000 or greater but less than 20,000, and which has 2 or more (meth)acryloyl groups per molecule; 2 parts by mass or more of a silicone C, the weight-average molecular weight of which is 300 or more but less than 1,000, the (meth)acrylic equivalent of which is less than 450 g/mol, and which has 2 or more (meth)acryloyl groups per molecule; and a radical initiator. | 2012-03-22 |
20120071605 | POLYMER COMPOSITIONS COMPRISING CYCLIC OLEFIN POLYMERS, POLYOLEFIN MODIFIERS AND NON-FUNCTIONALIZED PLASTICIZERS - This invention relates to a polymer composition comprising a blend comprising:
| 2012-03-22 |
20120071606 | POLYCARBONATE GRAFT COPOLYMERS - Methods of forming polycarbonate graft copolymers are provided. In particular, a polycarbonate polymer or copolymer containing allyl groups provides the backbone for the graft copolymer, and pendant chains are attached to the copolymer through the allyl groups. The graft copolymers exhibit a combination of high transparency, good graft levels, good scratch resistance, and/or good anti-fog properties. | 2012-03-22 |
20120071607 | CROSSLINKABLE POLYOLEFIN COMPOSITION COMPRISING SILANE GROUPS FORMING AN ACID OR A BASE UPON HYDROLYSATION - The present invention relates to a polyolefin composition comprising (A) a crosslinkable polyolefin with hydrolysable silane groups which upon hydrolysation form an acid or a base, characterised in that the acid or base generates a gel content of at least 40% after 40 hours in the 90° C. cross-linking test, wherein the acid or base is added in an amount of 4.5 mmol/kg to an ethylene/vinyltrimethoxysilane copolymer with a MFR | 2012-03-22 |
20120071608 | Copolymer Blend Compositions for Use to Increase Paper Filler Content - Methods for making a heterogeneous polymer blend comprising one or more anionic polymers, one or more cationic polymers, and one or more non-ionic polymers, which method comprises (a) adding to a non-neutral solution a first amount of polymerization initiator and one or more anionic or cationic monomers, wherein each monomer has the same charge; (b) a second amount of the polymerization initiator and one or more non-ionic monomers; (c) adding a third amount of the polymerization initiator and one or more ionic monomers that are oppositely charged from the monomers of (a); adding stepwise, a fourth amount of the polymerization initiator to react any residual monomer, and (e) neutralizing the resulting polymer blend. Also claimed are heterogeneous polymer blends containing polymers formed from one or more anionic, cationic, and non-ionic monomers, either polymerized in situ or separately and then combined. | 2012-03-22 |
20120071609 | Dew and Rain Harvesting with Superabsorbent Polymers - A method for harnessing rain and dew water with superabsorbent polymers. Highly absorbent superabsorbent polymers which are stimuli-responsive are used to absorb rain/dew water to augment water supply and solve water crisis. The polymers may be recycled and rehydrated number of times. They may be an additional source for drinking water. The polymers are used for storage of water in warehouses and the invention may obviate the need to construct controversial huge dams and canals or drill wells. The stored water in superabsorbent polymers is released at the point of use by any stimulus which may be mechanical, light-induced, electrical, thermal treatment or chemical treatment. Superabsorbent polymers with absorbing power of at least 1000 times their own weight are preferred. With 2000 g/g of swelling capacity, we can have 99.95% pure water in solid/gel form. In solid form, water can be transported anywhere without leakage. | 2012-03-22 |
20120071610 | REGIOFUNCTIONAL CARBON NANOTUBE BEAM AND METHOD - The present invention is generally directed toward a method to create an enhanced carbon nanotube spaceframe network. The spaceframe network contains an assembly of regiofunctional carbon nanotube beams by crown-to-crown connection into nodes to form a networked lattice configuration. The inventive method includes selecting crown materials and applying appropriate processing conditions which result in the production of secondary forms. The crown materials include polymers with unsaturated sites, polymeric crowns, silicon boron, poly(hydridocarbyne). The processing conditions include radical initiation, vulcanization, pyrolysis, hydroboration at unsaturation sites, using silicon bearing polymers in the Rf-CNB crowns, dissolution of silicon containing organics into the nodes and poly(hydridocarbyne). The secondary forms include cross-linked polymers, carbonized, graphitized, ceramic, diamond-like along with tailored functionalization. | 2012-03-22 |
20120071611 | POLYBENZOXAZINE-BASED COMPOUND, ELECTROLYTE MEMBRANE INCLUDING THE SAME, AND FUEL CELL EMPLOYING THE ELECTROLYTE MEMBRANE - A crosslinked object of a polybenzoxazine-based compound formed of a polymerized resultant of a first monofunctional benzoxazine-based monomer or a second multifunctional benzoxazine-based monomer with a crosslinkable compound, an electrolyte membrane including the crosslinked object, a method of preparing the electrolyte membrane, and a fuel cell employing the electrolyte membrane including the crosslinked object. | 2012-03-22 |
20120071612 | METHOD FOR THE PRODUCTION OF POLYAMINO ACID RANDOM COPOLYMERS - The present invention provides a method for the production of polyamino acid copolymers. In particular, the method may be utilized to produce high quality polyamino acid random copolymers. | 2012-03-22 |
20120071613 | Mixing Kneader and Process for Preparing Poly(Meth)Acrylates Using the Mixing Kneader - The invention relates to a mixing kneader comprising at least two shafts ( | 2012-03-22 |
20120071614 | CATALYST ON SILICA CLAD ALUMINA SUPPORT - The invention concerns catalysts comprising (i) a cladded catalyst support comprising (a) a core which comprises alumina particles and (b) about 1 to about 40 weight percent silica cladding, based on the weight of the cladded catalyst support, on the surface of the core; the catalyst support having a BET surface area of greater than 20 m2/g and a porosity of at least about 0.2 cc/g; and (ii) 0.1 to 10 weight percent, based on the weight of the catalyst, of catalytically active transition metal on the surface of the cladded catalyst support; wherein the catalyst support has a normalized sulfur uptake (NSU) of up to 25 ?g/m2. The invention also concerns the production and use of such catalysts. | 2012-03-22 |